← back to search

Nathan Erdmann

University of Alabama at Birmingham · US
Area of research
Neurology · Virology
Research interest
Research interests include Long-Term Effects of COVID-19, HIV Research and Treatment, COVID-19 Clinical Research Studies, and T-cell and B-cell Immunology.
h-index
21
citations
2,223
works
54
NIH funding
primary concept
Medicine
email

Recent publications

Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Nature Communications 2025cited by 8position: middledoi
Age‐Related Changes in the Clinical Picture of Long <scp>COVID</scp>
Journal of the American Geriatrics Society 2025cited by 2position: middledoi
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
Annals of Internal Medicine 2024cited by 42position: middledoi
The role of immune activation and antigen persistence in acute and long COVID
Journal of Investigative Medicine 2023cited by 59position: lastdoi
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries
Nature Genetics 2022cited by 136position: middledoi
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence
PLoS Pathogens 2021cited by 85position: middledoi
Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
JCI Insight 2021cited by 69position: lastdoi
Genetic regulation of <i>OAS1</i> nonsense-mediated decay underlies association with risk of severe COVID-19
medRxiv 2021cited by 12position: middledoi
Epidemiology of Infections in Adult Heart and Lung Transplant Recipients: A Single Center Experience
The Journal of Heart and Lung Transplantation 2021cited by 1position: lastdoi
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Journal of Clinical Investigation 2020cited by 160position: lastdoi
The tetraspanin CD151 marks a unique population of activated human T cells
Scientific Reports 2020cited by 16position: middledoi
Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts
AIDS 2015cited by 33position: middledoi
HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses
PLoS Pathogens 2015cited by 26position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Paul A. Goepfert · University of Alabama at Birmingham5 papers (2015–2021)Anju Bansal · University of Alabama at Birmingham4 papers (2015–2021)Jacob K. Files · University of Alabama at Birmingham4 papers (2020–2023)Sarah Sterrett · University of Alabama at Birmingham4 papers (2015–2021)Sushma Boppana · University of Alabama at Birmingham3 papers (2020–2021)Steffanie Sabbaj · University of Alabama at Birmingham3 papers (2020–2021)Kai Qin · University of Alabama at Birmingham3 papers (2020–2021)Olaf Kutsch · University of Alabama at Birmingham2 papers (2020–2020)Eric Carlin · University of Alabama at Birmingham2 papers (2020–2020)Mildred D. Perez · University of Alabama at Birmingham2 papers (2020–2020)Sanghita Sarkar · University of Alabama at Birmingham2 papers (2020–2021)Dustin M. Long · University of Alabama at Birmingham2 papers (2020–2021)James J. Kobie · University of Alabama at Birmingham2 papers (2020–2021)Kelsey E. Lowman · University of Alabama at Birmingham2 papers (2020–2020)Darío Dilernia · Emory University1 papers (2015–2015)Alexander S. Jureka · University of Alabama at Birmingham1 papers (2015–2015)Ronnie M. Russell · Integrated BioTherapeutics (United States)1 papers (2021–2021)John W. Baddley · Johns Hopkins University1 papers (2021–2021) · 1 papers (2021–2021)Jill Gilmour · University of Cape Town1 papers (2015–2015)